Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Cancer|October 1, 1994
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trialV Gebbia, G Cannata, A Testa, et al.
Tumori|June 30, 1992
The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitroV Gebbia, P Citarrella, V Miserendino, et al.
Anticancer Research|January 1, 1993
Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinomaV Gebbia, A Testa, R Valenza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective studyS Mercadante, A Casuccio, F Fulfaro, et al.
Blut|November 1, 1989
Analysis of human dysplastic haematopoiesis in long-term bone marrow cultureV Gebbia, V Miserendino, S Miceli, et al.
Anticancer Research|July 25, 1998
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinomaE Naglieri, V Gebbia, E Durini, et al.
La Clinica Terapeutica|March 15, 2023
Nutritional management of the patient with pancreatic cancer: from the diagnostic and therapeutic pathway to an integrated hospital-territory approachV Gebbia, R Cuggino, M Spada, et al.
La Clinica Terapeutica|June 15, 1999
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II studyV Gebbia, A Testa, N Borsellino, et al.
Anti-Cancer Drugs|August 1, 1992
Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapyV Gebbia, N Gebbia, A Russo, et al.
Anti-Cancer Drugs|March 1, 1997
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology GroupG Colucci, F Giotta, V Gebbia, et al.
Pageof 12